Compugen (CGEN) Income from Discontinued Operations (2009)
Compugen (CGEN) reported Income from Discontinued Operations of 5000.0 for Q2 2009.
Compugen (CGEN) Income from Discontinued Operations (2009) Analysis & Trends
Compugen (CGEN) has 1 years of Income from Discontinued Operations data on file, last reported at 5000.0 in Q2 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | - |
| 10 | Compugen | 223.15 Mn | 131.40 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2009 | 5,000.00 |